Clinical Trials Directory

Trials / Unknown

UnknownNCT04351932

Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis

Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Randomized Non Blind Controlled Clinical Trial

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Universidad Catolica Santiago de Guayaquil · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Mesenchymal stem cells (MSC) are stromal cells that have the ability to self-renew and also exhibit multilineage differentiation. MSCs can be isolated from a variety of tissues, such as umbilical cord, bone marrow, and adipose tissue. The multipotent properties of MSCs make them a promising option for the treatment of osteoarthritis (OA). Bone marrow mesenchymal stem cells (BM-MSC) and adipose derived mesenchymal stem cells (AD-MSC) have been used separately to treat OA. The aim of the present study will be to compare in a randomized non blind controlled clinical trial 3 types of intra-articular injections containing MSC populations obtained from two clinically relevant sources: BM-MSC, AD-MSC and a combination of both BM-MSC and AD-MSC.

Detailed description

The aim of the present study will be to compare 3 types of intra-articular injections of MSC populations obtained from two clinically relevant sources: injections containing BM-MSC or AD-MSC or a combination of both BM-MSC,and AD-MSC in a randomized non blind clinical trial. To assess the efficacy and safety of 3 kind of MSC injections in relation to pain, function and quality of life in patients with knee OA. A total of 54 patients with the diagnosis of knee OA grade II and III will be recruited to receive a single intra-articular injection of MSC: Group 1 (n 18 patients) will receive BM-MSC, Group 3 (n 18 patients) will receive AD-MSC. Group 3 (18 patients) will receive a combination of BM-MSC and AD-MSC. A randomized non blind clinical trial with active control. For this purpose, the random number generator is 54, found on the RANDOM.ORG ® website (available at https://www.random.org/integers/)

Conditions

Interventions

TypeNameDescription
BIOLOGICALbone marrow mesenchymal stem cellsintrarticular bone marrow mesenchymal stem cells injection
BIOLOGICALAdipose Mesenchymal stem cellsintrarticular adipose mesenchymal stem cells injection
BIOLOGICALbone marrow & adipose mesenchymal stem cells injectionintrarticular bone marrow and adipose stem cells injection.

Timeline

Start date
2020-06-07
Primary completion
2021-06-07
Completion
2021-09-07
First posted
2020-04-17
Last updated
2020-04-17

Locations

1 site across 1 country: Ecuador

Source: ClinicalTrials.gov record NCT04351932. Inclusion in this directory is not an endorsement.